Activity
Mon
Wed
Fri
Sun
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
What is this?
Less
More

Owned by Anthony

Where science meets results. Learn peptides, training, recovery & more. No ego, no fluff—just smarter bodies, better minds, built to adapt.

431 contributions to Castore: Built to Adapt
ATX-304 vs. MOTS-c: The pathway matters. The person matters more.
Two people walk into a consultation and tell me the same thing.“My energy is terrible.” The first has elevated glucose, excess body fat and evidence of insulin resistance. There is plenty of stored energy, but regulating and using that fuel may be part of the problem. The second is lean, training hard, sleeping five hours a night and cutting calories because they want to get leaner. Same complaint. Very different circumstances. If I hear “low energy” and immediately reach for an AMPK activator, I’ve skipped the part that determines whether my reasoning makes sense. What is actually limiting this person? That’s the conversation I want to have about ATX-304 and MOTS-c. Both connect to AMPK, but they reach it differently. Understanding those differences gets us much further than deciding which one sounds more powerful. Let’s begin with the cell’s energy conversation. ATP is the cell’s immediately usable energy currency. When ATP is spent, ADP and AMP help communicate changes in energy availability. AMPK helps respond to that information. It can adjust fuel handling and shift the balance between processes that consume energy and those that help restore it. Think about what you do when expenses rise faster than income. You look for ways to bring more in and become more selective about where it goes. Cells do something similar. But AMPK is not one simple on/off button. It’s a three-part complex. The alpha subunit does the catalytic work. The gamma subunit helps sense energy status by binding molecules such as AMP, ADP and ATP. The beta subunit helps hold the complex together and contributes to its regulation. For this comparison, remember two things: an energy-sensing component and an activating phosphate on the working component. That phosphate sits at a site called Thr172. That’s simply the threonine building block at position 172 on AMPK’s alpha subunit. Think of the phosphate as a tag attached at that location. Now we can see where the two compounds differ. ATX-304 helps preserve an active instruction.
0 likes • 17h
The part I’d revisit first is the six hours. There’s newer stuff showing nearly a four-day half-life for ATX-304. So yesterday’s dose is still very much part of today’s conversation. That doesn’t mean AMPK stays equally elevated for four days or that muscle growth gets put on hold. Half-life tells us how slowly the body clears the drug. How strongly it affects a pathway, in which tissue, and for how long are separate questions. The small human study reporting that half-life used daily dosing in people with obesity and prediabetes. Levels accumulated over approximately three weeks, with relatively little fluctuation between doses. That makes it difficult to argue that moving it a few hours away from training creates a clean separation. On the AMPK–mTOR side, you need both working together to adapt. AMPK helps coordinate fuel availability and energy use. mTOR, particularly the group of proteins called mTORC1, helps coordinate building new proteins when the conditions support it. Building muscle costs energy. AMPK helps the cell match what it spends with what it can supply. When energy stress is substantial, AMPK can apply brakes to mTORC1 through regulatory proteins called TSC2 and raptor. But how much braking occurs depends on the strength and duration of the signal, the tissue, and the resources available. We have human research where interval cycling increased AMPK activity, yet the muscle retained its mTORC1-related response to lifting afterward. That doesn’t establish that prolonged drug exposure behaves the same way. It does show why “AMPK went up, so growth shut down” skips several steps. With ATX, early experiments showed that it helps preserve a chemical tag that keeps AMPK active. That supports a sustained signal, but we still don’t know precisely how that translates into muscle protein synthesis in trained humans. The uncoupling adds another piece. Your mitochondria use energy from food to push positively charged particles called protons across a membrane. When those protons flow back through ATP synthase, that machinery makes ATP, the energy molecule your cells spend to do their work. I would think about water held behind a dam and getting directed through a turbine. With uncoupling, some water takes a route around the turbine. Some energy gets released as heat, and the mitochondria may process more fuel and consume more oxygen to maintain ATP production.
How much is guessing costing you?
You’re putting in the work. You’re investing in your training, nutrition and supplements. You’ve listened to the podcasts and read the explanations. But when progress stalls, you still find yourself wondering what to change. And if you coach people, that question carries even more weight. Someone is trusting you with their time, money and goals. They want to know why something isn’t working and what to do next. Imagine being able to walk through that conversation with a clearer understanding of what you’re looking for. You can explain the signal their training is sending, whether their nutrition supports that demand, and what their recovery is telling you. You can identify what deserves attention before adding another tool. You know what to watch and what would make you change direction. That’s the kind of thinking we’ll develop in the Pyramid. I built this six-week course for strength coaches and people who want to understand their own health and performance well enough to make better decisions. The Pyramid gives us an order to work through. We start with the environment the body is working in, then consider the adaptation we’re asking it to make, the resources needed to support it, and the tools that might help. Once you understand how those pieces fit together, the next step becomes easier to explain. For a coach, that knowledge has value every time a client asks a question, hits a plateau or arrives with a new supplement they saw online. You can spend less time chasing disconnected answers and more time working through a plan you can explain and evaluate. That’s how you build the trust that supports long-term client relationships, referrals and a stronger business. For your own health, the value is personal. You can make more deliberate choices about where your effort and money go, recognize when you’re adding complexity without a clear purpose, and understand what progress should look like. Here’s how we’ll build that understanding. Weeks 1–2: Understand the foundation
How much is guessing costing you?
FOX 04-DRI same day as GHRH/GHRPS
@Anthony Castore thouhjts on taking Fox 04 dri same day as GHRH/GHRP .. couple hours apart ??? Is there any sense to that or is better to just wait till I’m done with GHRH/GHRP before getting into Fox 04 dri … thanks As always for you input and anyone else 🙏
0 likes • 6d
Personally, I would not combine them on the same day, and I wouldn’t assume a couple of hours apart solves the concern. Let’s walk through what each one is asking your cells to do. GHRH and GHRPs encourage your pituitary the small gland beneath your brain to release growth hormone. Growth hormone can then increase IGF-1, another messenger that helps support growth and tissue maintenance. Think of this as a message being passed along, stimulate growth hormone, increase IGF-1, then deliver instructions to responsive cells. The strength and duration of that message depend on the compounds and how they’re used. Inside the cell, IGF-1 can activate a signaling chain called PI3K–AKT. You don’t need to memorize those letters. What matters here is that this chain can strengthen the cell’s “keep functioning and stay alive” instructions. Now we need to introduce p53. Think of p53 as part of the cell’s damage-inspection system. When something goes wrong, it helps coordinate the response. It will pause division, attempt repairs, or, under the right conditions, activate programmed cell death. ( apoptosis). It’s a controlled dismantling of the cell. One way AKT supports survival is through a protein called MDM2. MDM2 acts like a brake on p53, helping control how much p53 is available and how strongly it can act. In experimental studies, activating AKT can strengthen that brake. That is one connection between growth-factor signaling and a cell’s ability to resist death. FOXO4-DRI approaches the situation from another direction. FOXO4 is a protein your cells naturally make. In certain senescent cells—cells that have stopped dividing but remain alive, sometimes contributing to tissue dysfunction FOXO4 binds to p53 and helps prevent the cell from undergoing apoptosis. FOXO4-DRI was designed to interrupt that interaction. In the models studied, this allows active p53 to move out of the nucleus, the compartment holding the cell’s genetic instructions, and helps activate the machinery that dismantles the cell. The intended outcome is removal of susceptible senescent cells.
Anthony's Upcoming Optimization Cohort
Hello, gang! Just a short video giving the breakdown on @Anthony Castore's upcoming optimization course.
Anthony's Upcoming Optimization Cohort
1 like • 6d
Randy, this is awesome! Thank you! You've got a real gift for this, and you shared it without me even asking. I've been on The Mang Dojo a couple of times and loved every conversation. If you're not listening yet, start here 👇 https://open.spotify.com/show/29nUBARozqaEQr2s3ch94s The Mang Dojo episodes where I am a guest: S2E57 The Myth Of Dark Strength (with Chris Duffin) https://open.spotify.com/episode/6aLDHq2kavSvAXxnzRfoIY S2E56 "Grindatrutide" (with Chris Duffin) https://open.spotify.com/episode/1ySpAG9zgFCYipBh4O09Qx S1E52 Fighting The Reaper At The Cellular Level...And Doing It On A Budget (Part 2) https://open.spotify.com/episode/0hWndKBeWYknIsy5oyGc31 S1E51 Fighting The Reaper At The Cellular Level...And Doing It On A Budget (Part 1) https://open.spotify.com/episode/6bzUPJ8Z4PGRhKVuvzndNa
0 likes • 6d
@Randy Miyan I do as well!
Your fat has a job. Help it do it better.
Most people judge a fat loss plan by what happens on the scale. I understand that. You want your clothes to fit, your waist to come down, and the work you are putting in to show up somewhere besides your calendar. Those are legitimate goals. But there is another question worth asking along the way: how well is your body handling the energy moving through it? A new review in Science, "When fat adapts," brings that question into focus. Karima Drareni and Patrick Seale describe fat as a responsive organ whose function depends on its cells and their surroundings. My practical interpretation is that a good plan should improve both body composition and the body's ability to manage fuel. The scale can help us follow the first part. It cannot explain the whole story. Think of healthy fat tissue as a fuel depot. After a meal, it stores energy. Between meals and during activity, it releases some of that energy for other tissues to use. Having somewhere appropriate to put fuel is protective. Human genetic research links limited peripheral fat storage capacity with insulin resistance and cardiometabolic disease. Someone can therefore carry less visible fat while still having significant metabolic problems. Appearance gives us information, but it does not replace an assessment. The depot also needs infrastructure. Blood vessels deliver oxygen and nutrients. A supporting matrix gives the tissue structure. Immune cells help maintain and repair it. In human exercise research, regular exercisers had differences in these features compared with similar people who were sedentary, including more capillaries and fewer macrophages in abdominal fat beneath the skin. That is a much more interesting story than counting the calories displayed on a treadmill. Here is another useful distinction, removing fat and improving metabolism are different interventions. In a small human study, substantial abdominal liposuction did not significantly improve insulin sensitivity or the measured cardiovascular risk factors. That does not mean losing excess weight is unhelpful. It means we cannot assume every way of making a body smaller produces the same biological result. A cosmetic change should be evaluated as a cosmetic change unless broader benefits have actually been demonstrated.
1-10 of 431
Anthony Castore
7
2,429 points to level up
@anthony-castore-4271
Anthony Castore — SSRP Fellow & strength coach blending peptides, training, and cellular medicine to optimize performance and recovery.

Active 45m ago
Joined Jul 31, 2025
Powell, OH
Powered by